By Yale February 26, 2016 Leave a Comment

GestVision, led by founder and CEO Wendy Davis '14, has closed an A round of investment with an initial tranche of $2 million. The company's technology diagnoses preeclampsia with a simple dye-on-paper test.

About Yale

Leave a Reply

(required)

(required)


By Yale February 26, 2016 Leave a Comment

GestVision, led by founder and CEO Wendy Davis '14, has closed an A round of investment with an initial tranche of $2 million. The company's technology diagnoses preeclampsia with a simple dye-on-paper test.

About Yale

Leave a Reply

(required)

(required)


Copyright © 2017 MBAcrunch All Rights Reserved.